Torti Frank

SEC source: 0001140361-26-038474 · form4.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,495,893

F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

SEC source: 0001635088-26-000077 · wk-form4_1783033269.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,536,202

F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

SEC source: 0001764013-26-000052 · wk-form4_1775766671.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,325

Underlying: Common Stock · 88,325 shares

Expires 2036-04-07

F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest in substantially equal quarterly installments over two years measured from April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date.

SEC source: 0001764013-26-000052 · wk-form4_1775766671.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,009,228

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in substantially equal quarterly installments over two years measured from April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

SEC source: 0001635088-26-000036 · wk-form4_1775171687.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,576,512

F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · derivative · entry 9

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,026,184

Underlying: Common Shares · 587,390 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date (except as otherwise provided in the award documentation).

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · nonDerivative · entry 6

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,736,547

F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F4 · price: These Common Shares were sold in multiple transactions at prices ranging from $27.14 to $27.80, inclusive.

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · nonDerivative · entry 5

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,323,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · derivative · entry 8

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,613,574

Underlying: Common Shares · 1,012,610 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date (except as otherwise provided in the award documentation).

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · nonDerivative · entry 4

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,736,547

F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F3 · price: These Common Shares were sold in multiple transactions at prices ranging from $26.70 to $27.45, inclusive.

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · nonDerivative · entry 3

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,749,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · derivative · entry 7

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,626,184

Underlying: Common Shares · 1,400,000 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date (except as otherwise provided in the award documentation).

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · nonDerivative · entry 2

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,736,547

F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F2 · price: These Common Shares were sold in multiple transactions at prices ranging from $27.00 to $27.64, inclusive.

SEC source: 0001635088-26-000019 · wk-form4_1771897216.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,136,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-046788 · form4.xml · nonDerivative · entry 3

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,736,547

F4 · kind: The Reporting Person donated 110,489 Common Shares to a donor advised fund, which will use the gifted Common Shares for charitable purposes.

SEC source: 0001140361-25-046788 · form4.xml · nonDerivative · entry 2

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,847,036

F2 · price: The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F3 · price: Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1.

SEC source: 0001140361-25-046788 · form4.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,911,927

F1 · kind: Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.

F1 · price: Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.

SEC source: 0001140361-25-028453 · form4.xml · nonDerivative · entry 2

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,736,547

F2 · shares: Reflects an award of performance restricted stock units with respect to Common Shares ("PSUs") across six share price hurdle tranches, as follows: $15.00 (14.71% of PSUs); $17.50 (7.35% of PSUs); $20.00 (8.82% of PSUs); $22.50 (11.77% of PSUs); $25.00 (22.06% of PSUs); and $30.00 (35.29% of PSUs). The PSUs will vest tranche-by-tranche on the first date that both the performance condition and the service condition with respect to the applicable tranche of the PSUs has been satisfied. The performance condition will be deemed satisfied for each tranche of PSUs on the first date, during the performance period ending on July 26, 2029, when the Company's trailing 30-day volume weighted average trading price per share for trading days during the performance period exceeds the share price hurdle applicable to such tranche (as specified above). (Continued in footnote 3)

F3 · shares: (Continued from footnote 2) The service condition will be deemed satisfied for each tranche of PSUs on the first anniversary of the date on which the performance condition is first satisfied with respect to such tranche, subject to the reporting person's continuous service through such anniversary. In addition, following the satisfaction of the performance condition and service condition and the vesting of any tranche of the PSUs, the common shares underlying the applicable vested tranche of PSUs are subject to a further two-year holding period before such common shares may be sold.

SEC source: 0001140361-25-028453 · form4.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,836,547

F1 · shares: Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of March 31, 2025, which service-vest (i) 20% on the first anniversary of the vesting commencement date and (ii) in 16 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.

SEC source: 0001764013-25-000039 · wk-form4_1743712656.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,599

Underlying: Common Stock · 93,599 shares

Expires 2035-04-01

F2 · derivative.exercise_date: The shares underlying the options will vest in substantially equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date.

SEC source: 0001764013-25-000039 · wk-form4_1743712656.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 835,039

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

SEC source: 0001447028-24-000049 · wk-form4_1716581215.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,000

Underlying: Common Shares · 67,000 shares

Expires 2034-05-23

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.

F2 · derivative.exercise_date: The option is fully vested and exercisable as of the date of the grant.

SEC source: 0001764013-24-000059 · wk-form4_1712263442.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,167

Underlying: Common Stock · 50,167 shares

Expires 2034-04-02

F2 · derivative.exercise_date: The shares underlying the options will vest in substantially equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date.

SEC source: 0001764013-24-000059 · wk-form4_1712263442.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 635,674

F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

SEC source: 0001447028-23-000042 · wk-form4_1685131883.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Shares · 55,000 shares

Expires 2033-05-24

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant.

F2 · derivative.exercise_date: The option is fully vested and exercisable as of the date of the grant.

SEC source: 0001764013-23-000043 · wf-form4_168150413461709.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,292

Underlying: Common Stock · 158,292 shares

Expires 2033-04-12

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

SEC source: 0001764013-23-000043 · wf-form4_168150413461709.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,274

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

SEC source: 0001764013-22-000120 · wf-form4_166448284375026.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 393,358

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 - $5.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001764013-22-000089 · wf-form4_166094156090925.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,296

Underlying: Common Stock · 339,296 shares

Expires 2032-08-17

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

SEC source: 0001764013-22-000089 · wf-form4_166094156090925.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,358

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

SEC source: 0001447028-22-000035 · wf-form4_165359607419806.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,000

Underlying: Common Shares · 41,000 shares

Expires 2032-05-25

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant.

F2 · derivative.exercise_date: The option is fully vested and exercisable as of the date of the grant.

SEC source: 0001764013-22-000023 · wf-form4_164202558772198.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 554,748

Underlying: Common Stock · 329,485 shares

Expires 2032-01-10

F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

SEC source: 0001764013-22-000023 · wf-form4_164202558772198.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,726

F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs").

F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

SEC source: 0001447028-21-000039 · wf-form4_162309743051998.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2031-06-03

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on June 3, 2021, the date of the grant.

F2 · derivative.exercise_date: The options are fully vested and exercisable as of the date of the grant.

SEC source: 0001636050-21-000050 · wf-form4_161886583976808.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2031-04-14

F1 · derivative.exercise_date: 100% of this option will vest on April 15, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan.

SEC source: 0001764013-21-000044 · wf-form4_161650408026344.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,900

Underlying: Common Stock · 28,900 shares

Expires 2031-03-19

F2 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on March 19, 2022, subject to the Reporting Person's continuous service to the Issuer as of such date.

SEC source: 0001764013-21-000044 · wf-form4_161650408026344.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,600

F1 · shares: Represents the number of shares underlying restricted stock unit awards ("RSUs") granted to the Reporting Person pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in their entirety one year after the date of grant on March 19, 2022, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

SEC source: 0001447028-20-000066 · wf-form4_159104524972312.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2030-05-28

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 28, 2020, the date of the grant.

F2 · derivative.exercise_date: The options are fully vested and exercisable as of the date of the grant.

SEC source: 0001209191-20-029932 · doc4.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,600

Underlying: Common Stock · 42,600 shares

Expires 2030-05-14

F2 · derivative.exercise_date: The shares underlying the option vest in eight equal quarterly installments measured from May 15, 2020, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

SEC source: 0001209191-20-029932 · doc4.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,400

F1 · shares: Represents the number of shares underlying restricted stock units awards ("RSUs") pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in two equal annual installments on May 15, 2021 and May 15, 2022, subject to the Reporting Person's continued service to the Issuer as of each such date; provided that each director may elect to defer settlement of the RSUs upon vesting, subject to Rule 409A regulation.

F1 · price: Represents the number of shares underlying restricted stock units awards ("RSUs") pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in two equal annual installments on May 15, 2021 and May 15, 2022, subject to the Reporting Person's continued service to the Issuer as of each such date; provided that each director may elect to defer settlement of the RSUs upon vesting, subject to Rule 409A regulation.

SEC source: 0001209191-20-025020 · doc4.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Shares · 17,500 shares

Expires 2030-04-14

F1 · derivative.exercise_date: 100% of this option will vest on April 15, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.

SEC source: 0001209191-19-061602 · doc4.xml · derivative · entry 4

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,765

Underlying: Common Stock · 3,765 shares

Expires 2029-11-19

F5 · price: In connection with the Business Combination Transaction, the option to purchase 7,698 shares of Immunovant Sciences Ltd. at exercise price of $4.12 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer.

F1 · derivative.exercise_date: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter.

SEC source: 0001209191-19-061602 · doc4.xml · derivative · entry 3

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,488

Underlying: Common Stock · 11,488 shares

Expires 2029-10-20

F4 · price: In connection with the Business Combination Transaction, the option to purchase 23,489 shares of Immunovant Sciences Ltd. at exercise price of $4.12 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer.

F1 · derivative.exercise_date: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter.

SEC source: 0001209191-19-061602 · doc4.xml · derivative · entry 2

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 893

Underlying: Common Stock · 893 shares

Expires 2029-07-28

F3 · price: In connection with the Business Combination Transaction, the option to purchase 1,825 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer.

F1 · derivative.exercise_date: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter.

SEC source: 0001209191-19-061602 · doc4.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,617

Underlying: Common Stock · 137,617 shares

Expires 2029-06-19

F2 · price: In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation ("HSAC") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd. (the "Business Combination Transaction"), the option to purchase 281,387 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC).

F1 · derivative.exercise_date: 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter.

SEC source: 0001209191-19-047538 · doc4.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,608

Underlying: Common Shares · 58,608 shares

Expires 2029-08-22

F1 · derivative.exercise_date: 100% of the shares underlying the option vest and become exercisable on the earlier of (a) August 23, 2020, and (b) the date that is one day prior to the Issuer's 2020 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date.

SEC source: 0001447028-19-000050 · wf-form4_156633212358420.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2029-08-17

F1 · derivative.exercise_price: Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on August 16, 2019, the trading day immediately preceding the date of the grant.

SEC source: 0001209191-19-041793 · doc4.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Shares · 25,000 shares

Expires 2029-07-09

F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable on July 9, 2020, subject to the Reporting Person providing continuous service to the Issuer through such vesting date.

SEC source: 0001209191-19-025192 · doc4.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,000

Underlying: Common Stock · 255,000 shares

Expires 2029-04-14

F1 · derivative.exercise_date: 100% of this option will vest on April 15, 2020, subject to the Reporting Person providing continuous service to the Issuer on such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.

SEC source: 0001123292-18-001085 · edgar.xml · derivative · entry 1

Torti Frank · CIK 0001647805 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Shares · 44,000 shares

Expires 2028-11-26

F1 · derivative.exercise_date: The option will vest and become exercisable in three equal annual installments beginning November 26, 2019.